Global Opportunities of Bioabsorbable Stents Market in Next 3 Years

1. Global Opportunities of Bioabsorbable Stents Market in Next 3 Years The global bioresorbable stents market is expected to reach USD 417.2 million by 2022 from USD 242.4 million in 2017, at a CAGR of 11.5% during the forecast period. Download Free PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40983380 Some prominent players in the bioabsorbable stents market include Abbott (US), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (US), Elixir Medical Corporation (US), Arterial Remodeling Technologies (France), and Kyoto Medical Planning Co., Ltd. (Japan). Market growth of bioresorbable stents is attributed to the growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients’ preference for minimally invasive therapies. Bioabsorbable stents or scaffolds are implanted within the artery for clearing the blockage caused due to the accumulation of plaque (cholesterol, fatty substances, cellular waste products, calcium, and fibrin). These devices dissolve within the body after eluting the drug within a certain period of time and are aimed at increasing the efficiency of the treatment by reducing the chances of thrombosis and dual anti-platelet therapy among patients. Direct Purchase @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=40983380 Based on material, the market is segmented into bioresorbable polymer-based stents and bioresorbable metallic stents. The bioresorbable polymer-based stents segment is expected to grow at the highest CAGR. The growth of this market is mainly attributed to companies’ increasing focus on developing polymeric stents and increasing approvals for polymer-based stents across various regions Based on application, the market is segmented into coronary artery diseases and peripheral artery diseases. In 2017, coronary artery diseases accounted for the largest share of the market. The dominance of this segment is attributed to factors such as increasing aging population prone to coronary and the adoption of unhealthy lifestyle habits leading to increased risk of coronary artery diseases. Based on end users, the market is segmented into hospitals and cardiac centers. The hospitals segment is expected to dominate the market and grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to increasing need of

2. surgeries, growing risk of CAD and PAD, and improving reimbursement scenario for the hospitals. To speak to our analyst for a discussion on the above findings, click Speak to Analyst List of Figures (33 Figures) Figure 1 Bioresorbable Stents Market Figure 2 Research Design Figure 3 Key Data From Secondary Sources Figure 4 Key Data From Primary Sources Figure 5 Market Size Estimation: Bottom -Up Approach Figure 6 Market Size Estimation: Top-Down Approach Figure 7 Breakdown of Primary Interviews: By Company Type, Designation, and Region Figure 8 Data Triangulation Methodology Figure 9 Bioresorbable Polymer-Based Stents to Dominate the Market During the Forecast Period Figure 10 Bioresorbable Stents Market, By Absorption Rate (2017 vs 2022) Figure 11 Coronary Artery Disease to Register Highest Growth in the Bioresorbable Stents Application Market (2017-2022) Figure 12 Hospitals to Offer Significant Growth Opportunities During the Forecast Period Inquire before Buy @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=40983380 About MarketsandMarkets MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market competitors.

3. sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. the accuracy of the numbers. Contact: Mr. Shelly Singh Markets and Markets Tower No - B5 Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com